4QXU
Novel Inhibition Mechanism of Membrane Metalloprotease by an Exosite-Swiveling Conformational antibody
Summary for 4QXU
Entry DOI | 10.2210/pdb4qxu/pdb |
Related | 4OUU 4P3C 4P3D |
Descriptor | anti_MT1-MMP Light chain, anti_MT1-MMP Heavy chain, Matrix metalloproteinase-14, ... (5 entities in total) |
Functional Keywords | structural genomics, psi-2, protein structure initiative, israel structural proteomics center, ispc, igg fold, immune system |
Biological source | Mus musculus (mouse) More |
Cellular location | Membrane ; Single-pass type I membrane protein : P50281 |
Total number of polymer chains | 3 |
Total formula weight | 50642.37 |
Authors | Udi, Y.,Grossman, M.,Solomonov, I.,Dym, O.,Rozenberg, H.,Moreno, v.,Cuiniasse, P.,Dive, V.,Arroyo, A.G.,Sagi, I.,Israel Structural Proteomics Center (ISPC) (deposition date: 2014-07-22, release date: 2014-12-17, Last modification date: 2024-10-16) |
Primary citation | Udi, Y.,Grossman, M.,Solomonov, I.,Dym, O.,Rozenberg, H.,Moreno, V.,Cuniasse, P.,Dive, V.,Arroyo, A.G.,Sagi, I. Inhibition mechanism of membrane metalloprotease by an exosite-swiveling conformational antibody. Structure, 23:104-115, 2015 Cited by PubMed Abstract: Membrane type 1 metalloprotease (MT1-MMP) is a membrane-anchored, zinc-dependent protease. MT1-MMP is an important mediator of cell migration and invasion, and overexpression of this enzyme has been correlated with the malignancy of various tumor types. Therefore, modulators of MT1-MMP activity are proposed to possess therapeutic potential in numerous invasive diseases. Here we report the inhibition mode of MT1-MMP by LEM-2/15 antibody, which targets a surface epitope of MT1-MMP. Specifically, the crystal structures of Fab LEM-2/15 in complex with the MT1-MMP surface antigen suggest that conformational swiveling of the enzyme surface loop is required for effective binding and consequent inhibition of MT1-MMP activity on the cell membrane. This inhibition mechanism appears to be effective in controlling active MT1-MMP in endothelial cells and at the leading edge of migratory cancer cells. PubMed: 25482542DOI: 10.1016/j.str.2014.10.012 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.3 Å) |
Structure validation
Download full validation report
